Atorvastatin-d5 Sodium Salt
| Product Name |
Atorvastatin-d5 Sodium Salt
|
| Product Code |
DA-A331-45
|
| Chemical name |
Atorvastatin-d5 Sodium Salt
|
| Synonyms |
(βR,δR)-2-(4-Fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-(phenyl-d5)-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid Sodium ; Lipitor-d5 Sodium; (3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-(phenyl-d5)-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid, sodium salt;
|
| Impurity |
NA
|
| CAS Number |
222412-87-5
|
| Alternate CAS # |
NA
|
| Molecular form |
C33H29D5FN2NaO5
|
| Appearance |
Light Tan Solid
|
| Melting Point |
NA
|
| Mol. Weight |
585.65
|
| Storage |
2-8°C Hygroscopic, Refrigerator, Under inert atmosphere
|
| Solubility |
NA
|
| Stability |
NA
|
| Category |
chiral standards,intermediates,pharmaceutical standards,Fine Chemicals,stable isotopes
|
| Boiling Point |
NA
|
| Applications |
A deuterated selective, competitive HMG-CoA reductase inhibitor. Atorvastatin is the only drug in its class specfically indicated for lowering both elevated LDL-cholesterol and triglycerides in patients with hypercholesterolemia.
|
| Dangerous Goods Info |
NA
|
| References |
NA
|
| Extra Notes |
NA
|
| Documents (MSDS) |
No Data Available
|
| Keywords |
NA |
